Skip to content

Dietary guidance intervention study using CAND

Intervention effect of dietary guidance using CAND for liver dysfunction patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031200427
Enrollment
4
Registered
2021-03-17
Start date
2021-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver dysfunction

Interventions

Sponsors

Takara Tsuyoshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Male or female 3. Subjects aged 20 or more 4. Subjects whose AST is more than 38 IU/L, ALT is more than 44 IU/L, and gamma-GTP is more than 80 IU/L for males and 30 iU/L for females 5. Subjects who have been diagnosed with liver dysfunction

Exclusion criteria

Exclusion criteria: 1. Subjects who are judged as ineligible to participate in the study by the physician 2. Subjects who cannot receive the intervention on the planned date

Design outcomes

Primary

MeasureTime frame
1. The proportion of subjects whose AST is 38 IU/L or less after the intervention 2. The proportion of subjects whose ALT is 44 IU/L or less after the intervention 3. The proportion of subjects whose gamma-GTP is 80 IU/L or less for males and 30 iU/L or less for females after the intervention

Secondary

MeasureTime frame
1. The measured values of AST, ALT, and gamma-GTP at 8, 16 and 24 weeks after the start of the intervention

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc.

nao@orthomedico.jp+81-3-3813-5106

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026